Zimeishu: Honors Prove Strength, Building a Trusted Brand for Women's Intimate Care

Currently, with the release of the "Healthy China 2030" plan, the "Big Health" strategy has risen to a crucial national issue, and the women's health market is ushering in new development opportunities. At the same time, the current state of women's health in China remains concerning. Statistics show that the prevalence of cervicitis among women over 30 is as high as 45%, the rate of premature ovarian failure among women over 40 is close to 60%, nearly 70% of married women suffer from gynecological diseases to varying degrees, and over 80% of women will experience various gynecological inflammations at some point in their lives. Against this backdrop, Shaanxi Wan'an Pharmaceutical Co., Ltd., with over 30 years of experience in women's reproductive health, remains committed to "protecting women's health throughout their entire life cycle," meticulously cultivating its expertise in gynecological prevention and treatment. Its core brand, "Zimeishu," leveraging its robust technological qualifications and continuously iterating product capabilities, has expanded from national-level research projects to the lives of millions of women, demonstrating its strength through honors and building trust through patents.

Honor is often the outward manifestation of strength. As one of the carriers of the national-level Spark Program project,Zimeishu Medicated Padholds a national invention patent for "a traditional Chinese medicine preparation for the prevention and treatment of gynecological diseases and its preparation method and application" (patent number: ZL 2018 1 1045005.0). This innovative achievement, which integrates traditional Chinese medicine and modern technology, has become the core support for its technological barrier.

More notably, the product has passed dual medical device certifications, adheres to stringent medical device production standards, and undergoes independent aseptic packaging sterilized by cobalt-60 irradiation. Every indicator complies with GB15979-2002 "Hygienic Standard for Disposable Sanitary Products" and the company's proprietary standard (Q/SWY001-2022). Its test reports also bear both CMA and CNAS certification marks, providing both domestic legal protection and international mutual recognition. This "double insurance" allows the product to stand firm in market competition. From "Favorite Product for Chinese Women and Children" to "Recommended Health Products for Female Employees Nationwide," the Gold Award at the 9th China Patent New Technology and New Product Expo, and further to "Shaanxi Province High-Quality Development Benchmark Enterprise" and "Science and Technology-based Small and Medium-sized Enterprise," behind dozens of honors lies the industry's recognition of its scientific research strength and, more importantly, the accumulated trust of consumers in its quality.

Beneath this accolade lies a deep fusion of technology and humanism.Zimeishu Medicated Padbreaks through the functional limitations of traditional hygiene products, integrating prevention, adjunctive treatment, and daily care, redefining the feminine hygiene category with multi-dimensional prevention and treatment. Its core innovation lies in the organic combination of the essence of 38 kinds of traditional Chinese herbs with silver ion technology. Active ingredients such as matrine and osthol are extracted using CO₂supercritical extraction technology, combined with the physical antibacterial properties of silver ions, forming a dual-mode synergistic mechanism of "traditional Chinese medicine conditioning + physical protection."

This product is developed based on the "modern gynecological combined treatment concept," emphasizing a combination of prevention and treatment. Through "triple barrier protection," it aims to solve problems such as significant damage, high recurrence rate, and strong drug resistance in traditional gynecological prevention and treatment. It is particularly effective when used during key periods such as the three days before and four days after menstruation, enhancing protective efficacy and reducing the incidence of gynecological diseases. In terms of product design, theZimeishu Medicated PadGynecological Pads adopt a slightly moist, thin medicated patch form, with each pad containing approximately 4.5ml of standardized medication. Utilizing the rich microcirculation network of the female vulva, it facilitates a three-level absorption pathway of "vulva-mucosa-microcirculation," allowing the active ingredients to directly act on target tissues. This reduces the metabolic burden of traditional oral medications and overcomes the limitations of suppositories and washes.

Clinical observation data shows that theZimeishu Medicated PadGynecological Pads have an overall effective rate of over 90% for 12 common gynecological problems, with particularly significant improvements in symptoms such as vulvar eczema and fungal vaginitis. In vitro antibacterial experiments have also confirmed its clear inhibitory effect on common pathogenic bacteria such as Staphylococcus aureus and Candida albicans. In terms of usage scenarios, the product covers the entire physiological cycle of women, including menstruation, pregnancy, childbirth, and menopause, establishing a comprehensive health management system that integrates treatment, maintenance, conditioning, and prevention.

For over thirty years, through trials and tribulations, Shaanxi Wan'an Pharmaceutical Co., Ltd. has exemplified its development philosophy of integrity and technological innovation. From conducting nationwide health knowledge lectures for female employees to participating in the "Red Ribbon" health education campaign, the company has consistently upheld its social responsibility while creating economic benefits, investing over 100 million yuan in public welfare and science popularization to reach more women with health concepts. Today,Zimeishu Medicated Padhas built a nationwide marketing network, with products exported to Europe, America, Southeast Asia, and other countries and regions. Behind this success lies the backing of national-level scientific research projects, the support of multiple patented technologies, the guarantee of dual certification testing, and, most importantly, the accumulated reputation of millions of women.

Its growth trajectory also reflects the evolution of China's women's health industry from nothing to something, and from something to excellence. In today's era of rapid growth in the global reproductive health industry and increasingly strong domestic market demand, Zimeishu, with its forward-looking perspective of "prevention is better than cure," is responding to the modern woman's transformation in health concepts from "pleasing others" to "pleasing herself," and from passive treatment to proactive maintenance. Backed by both honors and strength, it is gradually building a brand ecosystem based on technology, bound by trust, and committed to women's health throughout their entire life cycle. In the future, as people's health needs become increasingly refined and professional,Zimeishu Medicated Padwill continue to delve into the field of women's reproductive health, enabling every woman to protect her intimate health with ease and confidence, and writing a legendary chapter of craftsmanship for Chinese women's intimate care brands.